Rumours aside, Manulife's merger options are few
Article Abstract:
Manufacturers Life Insurance's (Manulife) merger options are limited until such time that it will undergo demutualization or convert into a stock company. Since the firm has no publicly traded shares, it can not pay a company with a stock or merge via a stock swap. Although Manulife can raise its debt to fund a cash deal, this process is quite tedious and difficult since federal regulators would ensure that the firm has a solid balance sheet and credit rating before permitting the firm to take the loan. Unless Manulife goes public soon, the firm's plan to purchase Canada Trust will just have to wait.
Comment:
Merger options are limited until such time that it will undergo demutualization or convert into a stock company
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 1998
User Contributions:
Comment about this article or add new information about this topic:
Insurers set to kick sand at banks
Article Abstract:
The advantages of merger deals provided to the Canadian insurance industry in comparison to the Canadian Banks that face greater problems due mergers in their industry, is discussed.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
A different breed of deal maker is emerging
Article Abstract:
The managerial strategies of chief executive officers in business acquisitions of companies, such as Dofasco Inc., are presented.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Trash decision. The pulse seeds of discontent. Pandemic attack
- Abstracts: Running off the raodmap. The end of dreams
- Abstracts: Agrarians at the gate. A world of Old Mother Hubbards. Major major problems
- Abstracts: Ian Molson expected to voice opposition. Beware when the big boys start to quietly slip out of the market
- Abstracts: Molsom, Coors move to shore up support: Merger dissenters gaining momentum. Couche-Tard snubbed loyal investors